Published in Eur Respir J on February 20, 2008
Management of severe asthma in children. Lancet (2010) 1.60
Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD. Lung (2010) 1.09
A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation. Lung India (2016) 1.07
Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol (2011) 0.97
Techniques of assessing small airways dysfunction. Eur Clin Respir J (2014) 0.94
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Relat Outcome Meas (2014) 0.87
Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study. NPJ Prim Care Respir Med (2014) 0.85
Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations. J Asthma Allergy (2013) 0.84
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids. Allergy Asthma Immunol Res (2017) 0.81
Severe asthma in children. J Allergy Clin Immunol Pract (2014) 0.80
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment. Eur Respir J (2008) 0.79
Extrafine inhaled corticosteroid therapy in the control of asthma. J Asthma Allergy (2013) 0.78
Assessing small airways disease. Eur Respir J (2008) 0.77
Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs. J Pharm Sci (2016) 0.76
Small airways disease and severe asthma. World Allergy Organ J (2017) 0.75
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax (1999) 4.11
Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health (1996) 3.90
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J (2005) 3.66
Air pollution and development of asthma, allergy and infections in a birth cohort. Eur Respir J (2007) 3.42
Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med (2001) 3.40
[CBO guideline 'Deep venous thrombosis and pulmonary embolism; revision of the earlier guidelines. Dutch Organization for Quality Assurance in Hospitals]. Ned Tijdschr Geneeskd (2000) 3.32
Short-term effects of particulate air pollution on cardiovascular diseases in eight European cities. J Epidemiol Community Health (2002) 3.29
Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Air Pollution and Health: a European Approach. Am J Epidemiol (1997) 3.15
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med (1992) 3.13
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax (1999) 3.00
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax (2004) 2.85
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet (2001) 2.68
Coronary angiography with multi-slice computed tomography. Lancet (2001) 2.64
Incorporating out-patient data from CD-R into the local PACS using DICOM worklist features. J Digit Imaging (2005) 2.55
Asthma at 8 years of age in children born by caesarean section. Thorax (2008) 2.45
PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med (2001) 2.36
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis (1986) 2.29
Severe exacerbations predict excess lung function decline in asthma. Eur Respir J (2007) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med (2001) 2.08
Inhaled corticosteroids in COPD: a case in favour. Eur Respir J (2009) 2.06
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J (2004) 2.05
Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax (1997) 2.04
Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax (2000) 2.02
Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry (2000) 2.01
Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med (2001) 1.99
Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax (1992) 1.98
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Effects of long-term treatment with corticosteroids in COPD. Chest (1996) 1.94
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J (1994) 1.91
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J (2007) 1.90
Childhood factors associated with asthma remission after 30 year follow up. Thorax (2004) 1.90
Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax (1994) 1.84
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology (2002) 1.82
Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics (1994) 1.81
Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet (2000) 1.78
Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol (2007) 1.77
Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol (1993) 1.71
Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma. Allergy (2010) 1.70
A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol (1999) 1.67
Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol (2001) 1.65
Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sci (Lond) (1985) 1.64
Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet (2000) 1.63
Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J (2005) 1.62
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J (1998) 1.60
Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Air Pollution and Health: a European Approach. Arch Environ Health (1998) 1.59
Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J (2010) 1.58
The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J (1991) 1.57
Assessment of airway inflammation: an overview. Eur Respir J Suppl (1998) 1.55
Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy (2004) 1.55
Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches. Transplantation (2001) 1.55
Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children. Eur Respir J (1993) 1.54
Influence of in vivo prednisolone on increased in vitro O2- generation by neutrophils in emphysema. Eur Respir J (1993) 1.54
Childhood overweight and asthma symptoms, the role of pro-inflammatory proteins. Clin Exp Allergy (2011) 1.52
Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med (1999) 1.52
Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax (2003) 1.51
Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax (1994) 1.51
Pesticides and other occupational exposures are associated with airway obstruction: the LifeLines cohort study. Occup Environ Med (2013) 1.50
Conventional RIA underestimates cortisol suppression in the presence of prednisolone. Thorax (2002) 1.50
Less small airway dysfunction in asymptomatic bronchial hyperresponsiveness than in asthma. Allergy (2013) 1.48
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J (1992) 1.47
Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response. Allergy (2007) 1.47
Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism. A comparison with pulmonary angiography. Thromb Haemost (2000) 1.46
Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy (2003) 1.46
Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD. Respir Med (2006) 1.45
Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage (2002) 1.45
Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy (2005) 1.44
The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD. Clin Exp Allergy (1998) 1.44
[Good results in periodic screening in women with increased risk of breast cancer; retrospective study]. Ned Tijdschr Geneeskd (1995) 1.44
Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism. QJM (2000) 1.42
Indirect airway challenges. Eur Respir J (2003) 1.42
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy (1996) 1.41
Homocysteine and brain atrophy on MRI of non-demented elderly. Brain (2003) 1.40